175 related articles for article (PubMed ID: 21127766)
1. Warfarin: is the end nigh? Please?
Neilson RF
J R Coll Physicians Edinb; 2010 Sep; 40(3):222-3. PubMed ID: 21127766
[No Abstract] [Full Text] [Related]
2. Dabigatran etexilate (Pradaxa) for the treatment of atrial fibrillation.
Belavic JM
Nurse Pract; 2011 Sep; 36(9):6-7. PubMed ID: 21857210
[No Abstract] [Full Text] [Related]
3. Dabigatran for stroke prevention in atrial fibrillation: the RE-LY trial.
Paikin JS; Haroun MJ; Eikelboom JW
Expert Rev Cardiovasc Ther; 2011 Mar; 9(3):279-86. PubMed ID: 21438804
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of dabigatran compared to warfarin in patients with paroxysmal, persistent, and permanent atrial fibrillation: results from the RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) study.
Flaker G; Ezekowitz M; Yusuf S; Wallentin L; Noack H; Brueckmann M; Reilly P; Hohnloser SH; Connolly S
J Am Coll Cardiol; 2012 Feb; 59(9):854-5. PubMed ID: 22361407
[No Abstract] [Full Text] [Related]
5. Quality of anticoagulation control in atrial fibrillation.
Lane DA; Lip GY
Lancet; 2010 Sep; 376(9745):935-7. PubMed ID: 20801499
[No Abstract] [Full Text] [Related]
6. [Dabigatran: beyond the RE-LY study].
García Alegría J
Rev Clin Esp; 2012 Mar; 212 Suppl 2():1-3. PubMed ID: 23117715
[No Abstract] [Full Text] [Related]
7. At last, a RE-LYable alternative to warfarin for atrial fibrillation.
Hankey GJ
Int J Stroke; 2009 Dec; 4(6):454-5. PubMed ID: 19930055
[No Abstract] [Full Text] [Related]
8. Apixaban for stroke prevention in atrial fibrillation: a review of the clinical trial evidence.
Yates SW
Hosp Pract (1995); 2011 Oct; 39(4):7-16. PubMed ID: 22056819
[TBL] [Abstract][Full Text] [Related]
9. Another novel oral anticoagulant matches warfarin.
Mitka M
JAMA; 2014 Jan; 311(3):233-4. PubMed ID: 24430308
[No Abstract] [Full Text] [Related]
10. Insights from the dabigatran versus warfarin in patients with atrial fibrillation (RE-LY) trial.
Khoo CW; Lip GY
Expert Opin Pharmacother; 2010 Mar; 11(4):685-7. PubMed ID: 20105114
[TBL] [Abstract][Full Text] [Related]
11. Should dabigatran replace warfarin for stroke prevention in AF?
Drug Ther Bull; 2011 Oct; 49(10):114-7. PubMed ID: 21994438
[TBL] [Abstract][Full Text] [Related]
12. Dabigatran and warfarin in vitamin K antagonist-naive and -experienced cohorts with atrial fibrillation.
Ezekowitz MD; Wallentin L; Connolly SJ; Parekh A; Chernick MR; Pogue J; Aikens TH; Yang S; Reilly PA; Lip GY; Yusuf S;
Circulation; 2010 Nov; 122(22):2246-53. PubMed ID: 21147728
[TBL] [Abstract][Full Text] [Related]
13. Closing in on ending the warfarin era for stroke prevention in nonvalvular atrial fibrillation.
Turi ZG
Catheter Cardiovasc Interv; 2009 Aug; 74(2):223-4. PubMed ID: 19642149
[No Abstract] [Full Text] [Related]
14. Do ingredients make the difference?: finding the best cocktail of an anticoagulant with antiplatelets.
Sinnaeve PR; Van de Werf F
Circulation; 2013 Feb; 127(5):566-8. PubMed ID: 23271795
[No Abstract] [Full Text] [Related]
15. Dabigatran v warfarin. Compare with higher standard.
Edwards D
BMJ; 2010 Oct; 341():c5984. PubMed ID: 20978048
[No Abstract] [Full Text] [Related]
16. What are the emerging therapeutic alternatives to warfarin in stroke patients? How would the results of RE-LY benefit Pakistanis?
Khan M; Raza E; Kamal AK
J Pak Med Assoc; 2011 Jun; 61(6):612-3. PubMed ID: 22204226
[No Abstract] [Full Text] [Related]
17. Dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation: NICE guidance.
Ahmad Y; Lip GY
Heart; 2012 Oct; 98(19):1404-6. PubMed ID: 22698856
[No Abstract] [Full Text] [Related]
18. Is Apixaban (Eliquis) the "ideal" anticoagulant to replace warfarin for stroke prevention in atrial fibrillation?
Strain J; Templeton K
S D Med; 2013 Jan; 66(1):20-1. PubMed ID: 23342716
[No Abstract] [Full Text] [Related]
19. Atrial fibrillation: A promising new anticoagulant for stroke prevention.
Spinler SA
Nat Rev Cardiol; 2010 Jan; 7(1):10-1. PubMed ID: 20019756
[No Abstract] [Full Text] [Related]
20. Dabigatran: safer, more effective and easier to use than warfarin.
Cardiovasc J Afr; 2009; 20(5):311-2. PubMed ID: 19907807
[No Abstract] [Full Text] [Related]
[Next] [New Search]
